Clover Health Investments Price to Sales Ratio 2020-2023 | CLOV

Historical PS ratio values for Clover Health Investments (CLOV) over the last 10 years. The current P/S ratio for Clover Health Investments as of April 25, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Clover Health Investments P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-04-25 0.67 0.16
2023-12-31 0.95 $4.24 0.22
2023-09-30 1.08 $5.06 0.21
2023-06-30 0.90 $5.86 0.15
2023-03-31 0.85 $6.56 0.13
2022-12-31 0.93 $6.51 0.14
2022-09-30 1.70 $5.65 0.30
2022-06-30 2.14 $4.87 0.44
2021-12-31 3.72 $3.62 1.03
2021-09-30 7.39 $4.45 1.66
2021-06-30 13.32 $5.27 2.53
2021-03-31 7.56 $4.94 1.53
2020-12-31 16.77 $5.11 3.28
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.322B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.573B 22.01
Inspire Medical Systems (INSP) United States $7.095B 0.00
IRhythm Technologies (IRTC) United States $3.623B 0.00
Axonics (AXNX) United States $3.399B 0.00
10x Genomics (TXG) United States $3.279B 0.00
Enovis (ENOV) United States $3.080B 23.40
Azenta (AZTA) United States $2.905B 236.77
Olink Holding AB (publ) (OLK) Sweden $2.789B 0.00
Hims & Hers Health (HIMS) United States $2.644B 0.00
Privia Health (PRVA) United States $2.156B 95.63
Schrodinger (SDGR) United States $1.738B 0.00
Omnicell (OMCL) United States $1.260B 30.82
Phreesia (PHR) United States $1.237B 0.00
Definitive Healthcare (DH) United States $0.854B 0.00
Standard BioTools (LAB) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Pulmonx (LUNG) United States $0.290B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
P3 Health Partners (PIII) United States $0.158B 0.00
American Well (AMWL) United States $0.154B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.132B 0.00
TruBridge (TBRG) United States $0.116B 4.95
111 (YI) China $0.088B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00